SCHEMBL283957

SCHEMBL283957

CC(C)C1(N)CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
SLC6A4 P31645 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20104792 1.00 TSHR (0.31) TSHRCYP2C19SLC6A4SLC6A3
SCHEMBL284685 1.00 TSHR (0.31) TSHRCYP2C19SLC6A4SLC6A3
Fluoride SCHEMBL7235981 0.97
SCHEMBL1440208 0.97
SCHEMBL27867361 0.97
SCHEMBL27883620 0.97
SCHEMBL284625 0.97
SCHEMBL5223433 0.90
Acetic Acid SCHEMBL7704615 0.85 TSHR (0.33) TSHRCYP2C19
SCHEMBL23740108 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190834-A1 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF MINOR CANNABINOID COMPOUNDS FROM COMPLEX MIXTURES NECTAR HEALTH SCIENCES INC. (CA) 2024-06-13 US claimed
EP-3906224-B1 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS NECTAR HEALTH SCIENCES INC (CA) 2024-02-07 EP claimed
WO-2022115971-A9 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF MINOR CANNABINOID COMPOUNDS FROM CANNABIS NECTAR HEALTH SCIENCES INC. (CA) 2023-04-20 WO claimed
CN-112624149-B Silicon-aluminum phosphate molecular sieve material with LTA framework structure and preparation method and application thereof 中国科学院大连化学物理研究所 2023-04-07 CN claimed
EP-3677650-B1 INK COMPOSITION, METHOD FOR PRODUCING SAME, AND IMAGE FORMING METHOD FUJIFILM CORP (JP) 2022-09-28 EP claimed
WO-2022115971-A1 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF MINOR CANNABINOID COMPOUNDS FROM CANNABIS NECTAR HEALTH SCIENCES INC. (CA) 2022-06-09 WO claimed
EP-3906224-A1 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS Nectar Health Sciences Inc. (CA) 2021-11-10 EP claimed
CN-112624149-A Silicon-aluminum phosphate molecular sieve material with LTA framework structure and preparation method and application thereof 中国科学院大连化学物理研究所 2021-04-09 CN claimed
WO-2020248076-A1 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS NECTAR HEALTH SCIENCES INC. (CA) 2020-12-17 WO claimed
US-10640669-B2 Carbon black composition for manufacturing particulate magnetic recording medium and method of manufacturing particulate magnetic recording medium FUJIFILM CORPORATION (JP) 2020-05-05 US claimed
EP-1114021-B1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS LEK TOVARNA FARMACEVTSKIH (SI) 2004-07-14 EP claimed
US-6603022-B1 Reacting Lovastatin with a secondary amine under suitable conditions to form the corresponding amide intermediate, methylating the C-8 butyrate side chain, hydrolyzing to free carboxylic acid; lactonization BIOCON INDIA LIMITED (IN) 2003-08-05 US claimed
EP-0525880-B1 Catalytic alkylation process FMC CORP (US) 1998-05-06 EP claimed
EP-0644887-A1 PROCESS FOR THE PREPARATION OF CLAVULANIC ACID. SMITHKLINE BEECHAM PLC (GB) 1995-03-29 EP claimed
US-5332853-A Alkylating tetrachlorosilane or an alkylchlorosilane with an alkyllithium using ether, metal alkoxide, amine, or metal amide as catalyst FMC CORPORATION (US) 1994-07-26 US claimed
WO-1993025557-A1 PROCESS FOR THE PREPARATION OF CLAVULANIC ACID SMITHKLINE BEECHAM PLC (GB) 1993-12-23 WO claimed
EP-0525880-A1 Catalytic alkylation process FMC CORPORATION (US) 1993-02-03 EP claimed
US-4495229-A SECONDARY AMINE-BLOCKED POLYISOCYANATE-DEBLOCKING AT LOW TEMPERATURE CHEMISCHE WERKE HULS A.G. (DE) 1985-01-22 US claimed
US-4410730-A Process for the production of o-(N-monosubstituted amino)benzyl alcohols SHIONOGI & CO., LTD. (JP) 1983-10-18 US claimed
US-3996186-A TRIGLYCIDYL ISOCYANURATE-CYCLOHEXYLAMINE ADDUCTS, DIAMINE-DIGLYCIDYL ADDUCTS CIBA-GEIGY CORPORATION (US) 1976-12-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190834-A1 METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF MINOR CANNABINOID COMPOUNDS FROM COMPLEX MIXTURES CNR2, CNR1, BSG TSHR 4210/4885CYP2C19 2033/4885SLC6A4 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.